In contrast to pan T cell targeted CARs such as anti-CD7 CARs, the CD8 T cell population is not targeted in our CAR therapy and their persistence might decrease the risk of infections compared to other total T-cell directed CAR strategies. The gene discussed is CD7; the disease is infection.